© 2026 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Equity IPOs

Top Section/Ad

Top Section/Ad

Most recent


International tension has propelled valuations in the sector up, tempting issuers
Czech defence firm priced at a discount to German competitor Rheinmetall
Czech defence firm set for largest European IPO since Porsche's 2022 listing
Listing meant to give government fiscal breathing room
More articles/Ad

More articles/Ad

More articles

  • Thai Beverage has postponed the multi-billion-dollar spin-off and listing of its brewery unit in Singapore, citing choppy markets and a surge in Covid-19 cases in Thailand.
  • Trip.com Group's shares rose on its debut on the Hong Kong Stock Exchange on Monday, following a popular billion-dollar secondary listing by the Chinese travel company.
  • Allfunds, the B2B fund distribution platform, has opened the book on its Amsterdam IPO and named several high quality cornerstone investors which are backing the deal. However, not all deals are proving to be as popular as this one and bankers say the IPO market is splitting into those firms which can and those which cannot.
  • India’s Aditya Birla Sun Life Asset Management Company is gearing up for an IPO that will give its two promoter shareholders an opportunity to divest their positions in the firm.
  • The Indian government is looking for banks to help offload its stakes in Rashtriya Chemicals & Fertilizers and rival National Fertilizers, sending out two requests for proposals for the divestments.
  • Chinese company Zhaoke Ophthalmology has kicked off a Hong Kong IPO worth up to HK$2.1bn ($270m), becoming the latest biotechnology company to sell shares on the bourse.